HIV, cancer patients, transplant recipients not eligible for home isolation: Revised norms by Delhi govt
Team Udayavani, Jul 4, 2020, 8:24 AM IST
Delhi: COVID-19 patients suffering from immuno-compromised conditions such as cancer and HIV, and who have undergone any transplant procedures are not eligible for home isolation, according to revised guidelines issued by the Delhi government on Friday.
As per the revised norms issued by the Delhi health department, elderly people aged 60 and above, and having co-morbidities, can go for home isolation only after proper evaluation by a treating medical officer.
The patient should also download the Aarogya Setu app on mobile and keep it active all the time, it said.
The Directorate General of Health Services in Delhi said the revised guidelines on home isolation of very mildly symptomatic, pre-symptomatic, and asymptomatic patients supersede the order issued earlier.
The DGHS has also directed the district authorities to ensure that every COVID-19 patient who is home isolated has a pulse oximeter.
A pulse oximeter is a small, lightweight device used to monitor the amount of oxygen carried in the body.
For a patient to be eligible for home isolation, the person should be clinically assigned by a treating doctor as very mildly symptomatic or pre-symptomatic or asymptomatic, as per the guidelines.
Such patients should have the requisite facility at home for self-isolation and also for quarantining of family members, it said.
Patients suffering from immuno-compromised conditions such as cancer, HIV and who have undergone any transplant procedures will not be eligible for home isolation, the guidelines said.
Elderly persons, aged 60 and above, and suffering from co-morbid conditions such as hypertension, diabetes, heart disease, chronic lung, liver or kidney disease, or cerebrovascular diseases shall be allowed home isolation only after proper evaluation by a treating medical officer.
Someone should be available to provide care round-the-clock.
The care-giver and all persons coming in close contact of the patient should take hydrochloroquine prophylaxis as per the protocol and as prescribed by the treating medical officer, according to the revised norms.
The patient shall fill out an undertaking on self-solation and agree to follow all guidelines.
Immediate medical attention must be sought in case serious symptoms develop, like difficulty in breathing, dip in oxygen saturation level (Spo2 below 95 per cent), persistent pain or pressure in the chest and slurred speech or seizures, the guidelines said.
“Patient under home isolation shall stand discharged after 10 days from onset of symptoms and no fever for three days,” it said.
Thereafter, the patient will be advised to self-isolate and self-monitor their heath for another seven days.
There is no need for testing after the home isolation period is over, according to the revised guidelines.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Construction in ‘our own territory’ normal, says China on report of building village in Arunachal
Udupi youth builds dune buggy car out of scrap materials
Polytechnic Colleges in K’taka to be Upgraded & Modernised!
Related Articles More
Oxford preparing COVID-19 vaccine versions to fight virus variants: Report
Covid-19 vaccination: Karnataka reports 463 adverse events
K’taka COVID-19 update: 501 new cases, 665 discharges, 4 deaths on Jan 19
US couple celebrates 73rd wedding anniversary with vaccinations
47% of designated beneficiaries vaccinated on Jan 19 in Karnataka
explosion sound around shivamogga
Mangaluru harassment in bus case: Young woman narrates her ordeal
Harassment on city bus: Victim slaps ‘arrested’ molestor in front of police
Bricks Made From Used Plastic Water Bottles | Complete Information
Vijay Prakash | Self Charging Electric Bike Made by Autorickshaw driver
Mangaluru: Customs officials seize Rs 44.2 lakhs worth of gold from Dubai returnee
B’luru Airport recorded its first low-visibility landing under CAT IIIB
5 dead in fire at Covid-19 vaccine maker Serum Institute’s Manjari plant
India to face higher security challenges in line with rising stature, influence, says Army Chief Naravane
Commerce ministry recommends anti-dumping duty on Chinese chemical used in dye, Pharma industries